Fulgent Pharma
PrivateLast Round
M&A
Nov 7, 2022
Est. Valuation
$100M
Company Overview
Fulgent Pharma operates in Healthcare & Life Sciences and is based in El Monte, California. Its latest recorded funding round was a VC Round in April 2016.
Fulgent Pharma is a clinical-stage pharmaceutical company that develops and commercializes innovative cancer therapeutics using proprietary nanoencapsulation and targeted therapy platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fulgent Pharma Comparables
Compare Fulgent Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NantPharma | 84% | |
| Duo Oncology | 82% | |
| NanOlogy, LLC | 81% |
For institutional investors. Book with your work email.
Fulgent Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Nov 7, 2022 | ||||
| VC Round | Apr 14, 2016 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 46% MoM.
- Feb 15, 2026
Grew 150% QoQ from 2 to 5 employees.
For institutional investors. Book with your work email.
Fulgent Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Fulgent Pharma's valuation, stock price, and market status.
Is Fulgent Pharma a public or private company?
Fulgent Pharma is a private company.
What is the current stock price of Fulgent Pharma?
Fulgent Pharma is a private company, so its shares have no public market price. Caplight tracks Fulgent Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Fulgent Pharma worth (valuation)?
Fulgent Pharma's valuation is estimated at $100.0M based on funding round data.
Can I buy Fulgent Pharma stock?
Fulgent Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Fulgent Pharma's last funding round?
Fulgent Pharma's most recent funding round was M&A on November 7, 2022.
Who are the main investors in Fulgent Pharma?
Investor information for Fulgent Pharma is not publicly disclosed.
Will Fulgent Pharma IPO soon?
No public IPO plans have been announced for Fulgent Pharma.
How can I track Fulgent Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Fulgent Pharma's shares on secondary markets.